RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY — DEFINITIVE CONTRACT — HHSO100201700016C
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $973,560,406.91 |
| Submission deadline | Deadline not published |
| Published | Sep 28, 2017 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States · NY |
| CPV code | NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN13 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $973,560,406.91
- Submission deadline
- Deadline not published
- Published
- Sep 28, 2017
- Country
- United States
- CPV code
- NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN13
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS INC | US-UEI: N3F9MH7E6HD6 | United States | $973,560,406.91 | Sep 28, 2017 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
IGF
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.
PSC AN13: HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Period of Performance: 2017-09-30 to 2031-09-29.